Antibodies against HER2 truncated variant CTF-611

The present invention relates to a method of diagnosis and therapy of cancers expressing the HER2 receptor. The invention provides antibodies or fragments thereof that recognise an epitope of the HER2 receptor truncated form CTF-61 1, said epitope being defined by a sequence included in SEQ ID NO: 2...

Ausführliche Beschreibung

Bibliographische Detailangaben

Hauptverfasser:	ARRIBAS LÓPEZ, JOAQUÍN, PARRA PALAU, JOSEP LLUÍS, BASELGA TORRES, JOSÉ, ANGELLINI, PIER-DAVIDE, PEDERSEN, KIM
Format:	Patent
Sprache:	eng ; fre ; ger
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PHYSICS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS TESTING
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!